Cuprina Holdings Cayman Limited Asset Turnover Ratio (CUPR), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cuprina Holdings cayman Limited  (NASDAQ: CUPR)
 

Cuprina Holdings Cayman Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cuprina Holdings Cayman Limited's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the fourth quarter (Dec 31 2025)

Within sector 193 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 3885 to 4555.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CUPR Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change 223.3 % 415.4 % 561.2 % 415.4 % 66.5 %
Y / Y Revenue Change 9.2 % - - - -
Asset Turnover Ratio (TTM) 0.01 - - - 0.02
CUPR's Total Ranking # 4555 # 3885 # # #
Seq. Asset Change -0 % -22.05 % 28.29 % 223.3 % 59.42 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 194
Healthcare Sector # 636
Overall Market # 4555

Asset Turnover Ratio Statistics
High Average Low
0.01 0.01 0.01
(Dec 31 2025)  




CUPR Company Profile • Back to CUPR Efficiency Comparisons • Compare CUPR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Bellevue Life Sciences Acquisition Corp  0.02 $ 2.803  Millions$ 177.123  Millions
Co diagnostics Inc   0.01 $ 0.622  Millions$ 42.775  Millions
Rallybio Corporation  0.01 $ 0.858  Millions$ 59.727  Millions
Viskase Holdings inc   0.01 $ 1.921  Millions$ 134.034  Millions
Prime Medicine Inc   0.01 $ 4.632  Millions$ 333.729  Millions
Absci Corp  0.01 $ 2.800  Millions$ 225.907  Millions
Redhill Biopharma Ltd   0.01 $ 0.286  Millions$ 25.345  Millions
Vivosim Labs Inc   0.01 $ 0.142  Millions$ 12.741  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 6.636  Millions
Atrium Therapeutics Inc   0.01 $ 18.755  Millions$ 1,730.065  Millions
Vyne Therapeutics Inc   0.01 $ 0.533  Millions$ 49.552  Millions
Vistagen Therapeutics Inc   0.01 $ 0.790  Millions$ 79.634  Millions
Rafael Holdings Inc  0.01 $ 1.029  Millions$ 106.103  Millions
Clene Inc   0.01 $ 0.200  Millions$ 21.970  Millions
Puretech Health Plc  0.01 $ 4.659  Millions$ 534.710  Millions
Lyra Therapeutics Inc   0.01 $ 0.398  Millions$ 47.177  Millions
Cardiff Oncology Inc   0.01 $ 0.593  Millions$ 71.553  Millions
Cartesian Therapeutics Inc   0.01 $ 2.797  Millions$ 366.777  Millions
Upstream Bio Inc   0.01 $ 2.854  Millions$ 405.414  Millions
Kazia Therapeutics Limited  0.01 $ 0.042  Millions$ 6.061  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 7.696  Millions$ 1,243.297  Millions
Cuprina Holdings cayman Limited  0.01 $ 0.039  Millions$ 6.612  Millions
Ainos Inc   0.01 $ 0.124  Millions$ 23.456  Millions
Aclarion Inc   0.01 $ 0.076  Millions$ 14.527  Millions
Nakamoto Inc   0.01 $ 1.821  Millions$ 358.871  Millions
Lightwave Logic Inc 0.00 $ 0.237  Millions$ 48.012  Millions
Addex Therapeutics Ltd 0.00 $ 0.030  Millions$ 6.364  Millions
Dianthus Therapeutics Inc 0.00 $ 2.036  Millions$ 445.756  Millions
Oculis Holding Ag 0.00 $ 1.199  Millions$ 297.332  Millions
Silence Therapeutics Plc 0.00 $ 0.559  Millions$ 157.191  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.